Indications
Treatment of age-related macular degeneration (AMD) and visual impairment.
Composition
- Active substance
- aflibercept
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Skojoy
- Active substance
- aflibercept
- ATC code
- S01LA05
- Group
- Sensory organs
- Therapeutic area
- Wet Macular Degeneration, Macular Edema, Retinal Vein Occlusion, Choroidal Neovascularization
- Marketing authorisation holder
- Amgen Technology (Ireland) UC
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/006551